Your browser is no longer supported. Please, upgrade your browser.
LQDA [NASD]
Liquidia Corporation
Index- P/E- EPS (ttm)-1.80 Insider Own0.40% Shs Outstand40.82M Perf Week10.31%
Market Cap123.40M Forward P/E- EPS next Y-0.86 Insider Trans-96.03% Shs Float39.56M Perf Month6.64%
Income-59.80M PEG- EPS next Q-0.21 Inst Own32.80% Short Float5.07% Perf Quarter-2.03%
Sales0.70M P/S176.29 EPS this Y31.50% Inst Trans-25.17% Short Ratio1.39 Perf Half Y-15.25%
Book/sh1.74 P/B1.66 EPS next Y-7.50% ROA-85.70% Target Price4.50 Perf Year-53.16%
Cash/sh1.53 P/C1.89 EPS next 5Y- ROE-143.10% 52W Range2.34 - 12.10 Perf YTD-2.03%
Dividend- P/FCF- EPS past 5Y- ROI-71.60% 52W High-76.12% Beta-
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin67.90% 52W Low23.50% ATR0.18
Employees51 Current Ratio5.60 Sales Q/Q- Oper. Margin- RSI (14)57.53 Volatility7.84% 7.24%
OptionableYes Debt/Eq0.16 EPS Q/Q44.60% Profit Margin- Rel Volume0.36 Prev Close2.83
ShortableYes LT Debt/Eq0.15 EarningsMar 23 BMO Payout- Avg Volume1.44M Price2.89
Recom2.00 SMA2010.07% SMA500.62% SMA200-28.10% Volume515,509 Change2.12%
Dec-04-20Initiated H.C. Wainwright Buy $6
Nov-20-20Downgrade Wedbush Outperform → Neutral $20 → $4
Nov-08-18Resumed Jefferies Buy
Sep-05-18Initiated Wedbush Outperform $26
Aug-20-18Initiated Needham Buy $30
Aug-20-18Initiated Jefferies Buy $22
Apr-19-21 11:47AM  
Apr-13-21 07:00AM  
Apr-07-21 07:00AM  
Mar-30-21 07:00AM  
Mar-23-21 07:00AM  
06:30AM  
Mar-15-21 04:02AM  
Mar-09-21 07:30AM  
Mar-02-21 08:30AM  
Jan-04-21 03:11PM  
11:00AM  
Dec-31-20 04:21PM  
12:47PM  
Dec-23-20 12:40AM  
Dec-20-20 12:05AM  
Dec-16-20 04:42PM  
Dec-14-20 09:28AM  
02:39AM  
Dec-12-20 08:13PM  
Dec-10-20 09:10PM  
Dec-09-20 11:30PM  
Dec-07-20 08:22PM  
Dec-05-20 09:20PM  
Nov-30-20 08:55PM  
08:49PM  
07:15AM  
Nov-29-20 07:45AM  
Nov-26-20 09:14AM  
Nov-25-20 11:10PM  
07:35AM  
07:00AM  
Nov-24-20 08:12AM  
Nov-22-20 07:22AM  
Nov-18-20 04:01PM  
Nov-16-20 07:15AM  
Nov-12-20 10:06AM  
Nov-09-20 07:15AM  
06:15AM  
Nov-02-20 07:15AM  
Oct-30-20 08:40PM  
04:15PM  
Oct-19-20 02:50PM  
08:30AM  
Oct-14-20 09:25AM  
Oct-05-20 07:15AM  
Sep-17-20 07:15AM  
Sep-14-20 01:04PM  
Aug-28-20 07:15AM  
Aug-20-20 09:15AM  
Aug-10-20 07:15AM  
Aug-05-20 05:30PM  
07:15AM  
Aug-03-20 09:20AM  
Jul-24-20 09:08AM  
Jul-08-20 10:35PM  
Jul-02-20 04:01PM  
Jun-30-20 07:41AM  
Jun-29-20 10:45PM  
10:30PM  
04:05PM  
04:01PM  
Jun-16-20 08:20AM  
Jun-12-20 07:09PM  
Jun-05-20 03:30PM  
May-29-20 10:31AM  
May-27-20 08:04PM  
May-22-20 10:01AM  
May-18-20 07:15AM  
May-11-20 04:01PM  
May-07-20 09:30AM  
May-06-20 06:30PM  
Apr-30-20 07:30AM  
Apr-09-20 07:30AM  
Apr-08-20 07:45AM  
Mar-11-20 08:15AM  
07:00AM  
Mar-04-20 12:30PM  
Feb-26-20 04:30PM  
04:30PM  
Jan-27-20 02:55PM  
08:00AM  
Jan-24-20 09:00AM  
Jan-15-20 07:29AM  
Dec-26-19 02:55PM  
10:32AM  
Dec-24-19 08:30AM  
Dec-20-19 06:21PM  
Nov-13-19 08:15AM  
07:00AM  
06:00AM  
Nov-06-19 08:00AM  
Nov-01-19 08:00AM  
Oct-23-19 10:33AM  
Oct-22-19 10:52AM  
Sep-25-19 04:05PM  
Sep-12-19 04:05PM  
Sep-03-19 07:00AM  
Aug-27-19 02:44PM  
Aug-08-19 04:05PM  
07:00AM  
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Manning Paul BDirectorApr 13Buy2.52198,413500,001737,646Apr 15 09:24 AM
JEFFS ROGERDirectorApr 13Buy2.5299,206249,999111,706Apr 15 09:22 AM
Eshelman Ventures, LLC10% OwnerJan 26Sale3.121,762,1625,502,5272,601,210Jan 27 04:32 PM
Eshelman Ventures, LLC10% OwnerJan 25Sale2.97719,2872,139,0164,363,372Jan 26 05:27 PM
Eshelman Ventures, LLC10% OwnerJan 22Sale2.95500,0001,473,3005,082,659Jan 26 05:27 PM
Eshelman Ventures, LLC10% OwnerJan 21Sale2.96328,250972,0805,582,659Jan 22 04:20 PM
Eshelman Ventures, LLC10% OwnerJan 20Sale2.9553,405157,7695,910,909Jan 21 05:04 PM
Eshelman Ventures, LLC10% OwnerJan 19Sale2.9793,835279,0285,964,314Jan 21 05:04 PM
Eshelman Ventures, LLC10% OwnerJan 15Sale3.0127,00081,2516,058,149Jan 19 05:20 PM
Eshelman Ventures, LLC10% OwnerJan 14Sale3.0234,466103,9186,085,149Jan 15 05:44 PM
Eshelman Ventures, LLC10% OwnerJan 13Sale3.073,39310,4166,119,615Jan 15 05:44 PM
Eshelman Ventures, LLC10% OwnerJan 12Sale3.0699,335304,4026,123,008Jan 13 06:00 PM
Eshelman Ventures, LLC10% OwnerJan 11Sale3.0513,52441,2506,222,343Jan 13 06:00 PM
Eshelman Ventures, LLC10% OwnerJan 08Sale3.0871,902221,5086,235,867Jan 11 05:50 PM
Eshelman Ventures, LLC10% OwnerJan 07Sale3.12142,819445,6386,307,769Jan 11 05:50 PM
Eshelman Ventures, LLC10% OwnerDec 22Sale3.147,94924,9606,450,588Dec 28 05:20 PM
Eshelman Ventures, LLC10% OwnerDec 21Sale3.1351,906162,4666,458,537Dec 22 07:08 PM
Eshelman Ventures, LLC10% OwnerDec 18Sale3.1453,309167,4706,510,443Dec 22 07:08 PM
Eshelman Ventures, LLC10% OwnerDec 14Sale3.136,41720,0856,563,752Dec 16 05:11 PM
Eshelman Ventures, LLC10% OwnerNov 30Sale3.132006266,570,169Dec 01 08:56 PM
Eshelman Ventures, LLC10% OwnerNov 27Sale3.132006266,570,369Dec 01 08:56 PM
Eshelman Ventures, LLC10% OwnerNov 25Sale3.1317,36454,3496,570,569Dec 01 08:34 PM
Eshelman Ventures, LLC10% OwnerNov 24Sale3.15283,465894,2476,587,933Dec 01 08:34 PM
Eshelman Ventures, LLC10% OwnerNov 23Sale3.16133,346421,3476,871,398Dec 01 08:34 PM
Eshelman Ventures, LLC10% OwnerNov 19Sale3.3530,000100,5007,004,744Dec 01 08:34 PM
Eshelman Ventures, LLC10% OwnerJul 02Buy8.001,875,00015,000,0007,034,744Jul 02 07:31 PM
Maynor BenjaminSVP, Research and DevelopmentMay 27Option Exercise2.694,75412,78811,735May 28 04:30 PM